A Review on Vyadhi Shardul Guggulu in the Management of Amavata (Rheumatoid Arthritis)

RA follows a chronic course characterized by fluctuating periods of exacerbation and remission, with considerable variability in severity. In Ayurvedic texts the condition known as Amavata first described by Acharya Madhavakara is considered analogous to RA. The pathogenesis of Amavata involves the interplay of Ama (metabolic toxins) and Vata (biological energy associated with movement). Aim: This study aims to evaluate the pharmacological mechanisms of action of the ingredients in Vyadhi Shardul Guggulu, a classical Ayurvedic formulation, and to assess its therapeutic potential in alleviating the symptoms of Amavata, with specific reference to rheumatoid arthritis. Methodology: Vyadhi Shardul Guggulu, as documented in the Ayurvedic text Bhaishajya Ratnavali, is traditionally employed in the management of Amavata. A comprehensive review was conducted using peer-reviewed scientific literature, classical Ayurvedic texts, modern rheumatology references, and online databases. Keywords such as Amavata, rheumatoid arthritis, and Vyadhi Shardul Guggulu guided the literature search and analysis. Conclusion: The formulation exhibits properties including Deepana (enhancement of digestive fire), Pachana (metabolic stimulation), Shothahara (anti-inflammatory), and Vedanahara (analgesic), which collectively contribute to interrupting the Samprapti (pathophysiological progression) of Amavata. This review highlights the classical references, pharmacodynamic attributes, and clinical relevance of Vyadhi Shardul Guggulu in the integrative management of rheumatoid arthritis.